Maven Securities
DMK

Maven Securities’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Maven Securities’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,286
Closed -$795K – 913
2020
Q3 		$795K Buy
+14,286
New +$847K 0.07% 290

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RVW Wealth
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Maven Securities's DMK Position: Q4 2020 in Review

Maven Securities sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2020, closing a stake of 14,286 shares — an estimated $795K sold.

Maven Securities first reported a position in DMK in Q3 2020 and held it in 1 quarter. The position peaked at $795K in Q3 2020. 41 funds tracked by Wall St. Rank hold DMK as of Q4 2020.

  • Maven Securities reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2020 after selling out during the quarter.
  • Maven Securities sold 14,286 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2020, an estimated $795K.
  • Maven Securities first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2020 and held it in 1 quarter.
  • Maven Securities's DMK Pharmaceuticals Corporation Common Stock position peaked at $795K in Q3 2020.
  • 41 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2020.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.